http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0994696-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_781234f3bbb66c6fda75dc8db9f2a283
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 1998-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2244777cf26637dc803987584fc94e4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4906ebde002256f3f8b2e81b5caff715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7e3ba46fff1b68068cf651526ad2073
publicationDate 2004-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0994696-B1
titleOfInvention Controlled release pharmaceutical preparation with ace inhibitor as active agent
abstract The invention relates to a pharmaceutical preparation which comprises or consists of the following components:(i) an initial dose of active ingredient, which is provided by the active ingredient together with optional excipients,(ii) a first delayed-release type of pellet, in which the active ingredient and optional excipients are covered with a coating, and(iii) a second delayed-release type of pellet, in which the active ingredient and optional excipients are again covered with a coating,wherein the active ingredient is an ACE inhibitor, andwherein the amounts of the coatings according to (ii) and (iii) are present in a ratio, based on weight, within the range of from 1:2 to 1:7.
priorityDate 1997-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID34189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136080371
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID509484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400268
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6432616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393233
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6506
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID34805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420555
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID59272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127805888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128043208
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128319806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127763702
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406927
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID613133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406413
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129432080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19710891
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128203001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10351092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18799105
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID101824864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128756890
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID449567
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID843628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412164
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128104191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18458326
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID419953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443953
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1636
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408288
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID610668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107807

Total number of triples: 85.